ATE519502T1 - Kohlenhydratkonjugate zur verhinderung des missbrauchs kontrollierter substanzen - Google Patents
Kohlenhydratkonjugate zur verhinderung des missbrauchs kontrollierter substanzenInfo
- Publication number
- ATE519502T1 ATE519502T1 AT04701730T AT04701730T ATE519502T1 AT E519502 T1 ATE519502 T1 AT E519502T1 AT 04701730 T AT04701730 T AT 04701730T AT 04701730 T AT04701730 T AT 04701730T AT E519502 T1 ATE519502 T1 AT E519502T1
- Authority
- AT
- Austria
- Prior art keywords
- abuse
- substance
- preventing
- controlled substance
- controlled substances
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Paper (AREA)
- Steroid Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43946803P | 2003-01-13 | 2003-01-13 | |
| PCT/US2004/000646 WO2004062614A2 (en) | 2003-01-13 | 2004-01-13 | Carbohydrate conjugates to prevent abuse of controlled substances |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE519502T1 true ATE519502T1 (de) | 2011-08-15 |
Family
ID=32713487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04701730T ATE519502T1 (de) | 2003-01-13 | 2004-01-13 | Kohlenhydratkonjugate zur verhinderung des missbrauchs kontrollierter substanzen |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1594513B1 (de) |
| JP (1) | JP2006515622A (de) |
| KR (1) | KR20050098246A (de) |
| CN (1) | CN1747737A (de) |
| AT (1) | ATE519502T1 (de) |
| AU (1) | AU2004204804C1 (de) |
| CA (1) | CA2512951A1 (de) |
| ES (1) | ES2371462T3 (de) |
| IL (1) | IL169645A0 (de) |
| WO (1) | WO2004062614A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7943586B2 (en) | 2003-06-09 | 2011-05-17 | The Trustees Of The University Of Pennsylvania | Antineoplastic agents targeted via glut transporters |
| MX2008014794A (es) * | 2006-05-26 | 2009-04-08 | Pharmacofore Inc | Liberacion controlada de opioides fenolicos. |
| US8486448B2 (en) | 2007-12-17 | 2013-07-16 | Paladin Labs Inc. | Misuse preventative, controlled release formulation |
| ES2509497T3 (es) | 2008-12-16 | 2014-10-17 | Paladin Labs Inc. | Formulación de liberación controlada para evitar un uso indebido |
| US10335406B2 (en) | 2015-10-01 | 2019-07-02 | Elysium Therapeutics, Inc. | Opioid compositions resistant to overdose and abuse |
| AU2016332071B2 (en) * | 2015-10-01 | 2019-04-18 | Elysium Therapeutics, Inc. | Polysubunit opioid prodrugs resistant to overdose and abuse |
| EP3595663A4 (de) | 2017-03-17 | 2021-01-13 | Elysium Therapeutics, Inc. | Mehrfachuntereinheit-opioid-prodrugs mit resistenz gegen überdosierung und missbrauch |
| CN116115768B (zh) * | 2022-12-01 | 2025-03-18 | 西南民族大学 | 一种抗菌剂及其制备方法和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6548484B1 (en) * | 2000-04-12 | 2003-04-15 | International Medical Innovations, Inc. | Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation |
| US20030130205A1 (en) * | 2000-04-12 | 2003-07-10 | Christian Samuel T. | Novel pharmaceutical anti-infective agents containing carbohydrate moieties and methods of their preparation and use |
| US20020099013A1 (en) * | 2000-11-14 | 2002-07-25 | Thomas Piccariello | Active agent delivery systems and methods for protecting and administering active agents |
| ES2383673T3 (es) * | 2000-09-22 | 2012-06-25 | Jpi Commercial, Llc | Composiciones de gamma-hidroxibutirato que contienen portadores de hidrato de carbonos |
| AU2002313628A1 (en) * | 2001-05-22 | 2002-12-03 | Euro-Celtique | Tamper resistant oral dosage form |
| US6713452B2 (en) * | 2001-06-04 | 2004-03-30 | Nobex Corporation | Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| AU2003210454A1 (en) * | 2002-01-08 | 2003-07-24 | New River Pharmaceuticals, Inc. | Dendritic encapsulation of active agents |
| KR100822498B1 (ko) * | 2002-02-22 | 2008-04-16 | 샤이어 엘엘씨 | 규제된 물질의 남용을 방지하기 위한 새로운 서방성 약학화합물 |
| ATE482695T1 (de) * | 2002-12-13 | 2010-10-15 | Durect Corp | Orale darreichungsform mit flüssigen hochviskosen trägersystemen |
-
2004
- 2004-01-13 JP JP2006500902A patent/JP2006515622A/ja active Pending
- 2004-01-13 KR KR1020057012951A patent/KR20050098246A/ko not_active Withdrawn
- 2004-01-13 ES ES04701730T patent/ES2371462T3/es not_active Expired - Lifetime
- 2004-01-13 AT AT04701730T patent/ATE519502T1/de not_active IP Right Cessation
- 2004-01-13 AU AU2004204804A patent/AU2004204804C1/en not_active Ceased
- 2004-01-13 EP EP04701730A patent/EP1594513B1/de not_active Expired - Lifetime
- 2004-01-13 CA CA002512951A patent/CA2512951A1/en not_active Abandoned
- 2004-01-13 CN CNA2004800040107A patent/CN1747737A/zh active Pending
- 2004-01-13 WO PCT/US2004/000646 patent/WO2004062614A2/en not_active Ceased
-
2005
- 2005-07-12 IL IL169645A patent/IL169645A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1594513A4 (de) | 2009-02-04 |
| ES2371462T3 (es) | 2012-01-03 |
| AU2004204804C1 (en) | 2010-11-18 |
| JP2006515622A (ja) | 2006-06-01 |
| AU2004204804B2 (en) | 2010-06-24 |
| AU2004204804A1 (en) | 2004-07-29 |
| WO2004062614A3 (en) | 2005-05-06 |
| EP1594513A2 (de) | 2005-11-16 |
| IL169645A0 (en) | 2007-07-04 |
| WO2004062614A2 (en) | 2004-07-29 |
| CA2512951A1 (en) | 2004-07-29 |
| EP1594513B1 (de) | 2011-08-10 |
| CN1747737A (zh) | 2006-03-15 |
| KR20050098246A (ko) | 2005-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG155054A1 (en) | Human anti- neutralizing antibodies as selective pathway inhibitors | |
| DK1075282T3 (da) | PEG-LHRH-analog-konjugater | |
| SG164369A1 (en) | Human anti-b7rp1 neutralizing antibodies | |
| EP1796666A4 (de) | Verfahren und zusammensetzungen zur behandlung von hyperlipidämie | |
| DE69433818D1 (de) | Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung | |
| UA85993C2 (ru) | Конъюгат, который содержит бактериальный суперантиген и антительную составную, фармацевтическая композиция, которая его содержит, и способ лечения рака у млекопитающего | |
| ATE339406T1 (de) | Chinazoline verbindungen als heilmittel | |
| AU2002324914A1 (en) | Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith | |
| EP2357006A3 (de) | Arzneimittelkonjugate und deren Verwendung zur Behandlung von Krebs, einer Autoimmunerkrankung oder einer Infektionskrankheit | |
| BR0110530A (pt) | Composições farmacêuticas contendo um antibiótico glicopeptìdico e uma ciclodextrina | |
| ATE430555T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von asthma | |
| MY137828A (en) | Keratinocytes which may be used as a biologically active substances for the treatment of wounds | |
| EP1505990A4 (de) | Verfahren zur behandlung von hepatitis | |
| BRPI0410049A (pt) | composto ou um sal ou estereoisÈmero farmaceuticamente aceitável do mesmo, uso de um composto, composição farmacêutica, e, kit farmacêutico | |
| EP1572118A4 (de) | Verfahren und zusammensetzungen zur behandlung von krebs mit 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216 | |
| EP1773369A4 (de) | Pharmazeutische zusammensetzungen und verfahren für die peptidbehandlung | |
| ATE519502T1 (de) | Kohlenhydratkonjugate zur verhinderung des missbrauchs kontrollierter substanzen | |
| EP1978034A4 (de) | Antiperiostin-antikörper und pharmazeutische zusammensetzung zur prävention oder behandlung von mit periostin in zusammenhang stehenden krankheiten, die diese enthält | |
| PL1781277T3 (pl) | Kompozycja łączona zawierająca ibuprofen i paracetamol | |
| WO2007005941A3 (en) | Liver targeted conjugates | |
| DE60027905D1 (de) | Glycokonjugate, glycoaminosäure, deren zwischenprodukte, und ihre verwendung | |
| TW200806293A (en) | Methods of treatment with CETP inhibitors | |
| PT1165159E (pt) | Suportes oligossacarídicos para e.g. a remoção de anticorpos do sangue | |
| FR2877576B1 (fr) | Composition pharmaceutique utilisee pour stimuler la proliferation et l'activation des mastocytes | |
| DE10081194D2 (de) | Darreichungsform zur Applikation in Körperöffnungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |